276 related articles for article (PubMed ID: 1540486)
1. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Br J Clin Pharmacol; 1992 Jan; 33(1):25-31. PubMed ID: 1540486
[TBL] [Abstract][Full Text] [Related]
2. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Stewart GA; Thompson PJ
Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
[TBL] [Abstract][Full Text] [Related]
4. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
May JA; Heptinstall S; Cole AT; Hawkey CJ
Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
[TBL] [Abstract][Full Text] [Related]
5. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
6. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
Gentry PA; Niemuller C; Ross ML; Liptrap RM
Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
[TBL] [Abstract][Full Text] [Related]
8. Role of thromboxane A2 as a mediator of platelet-activating-factor-induced aggregation of human platelets.
McCulloch RK; Summers J; Vandongen R; Rouse IL
Clin Sci (Lond); 1989 Jul; 77(1):99-103. PubMed ID: 2758765
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
Küster LJ; Frölich JC
Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760
[TBL] [Abstract][Full Text] [Related]
10. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation.
Altman R; Scazziota A; Dujovne C
Clin Pharmacol Ther; 1988 Sep; 44(3):320-5. PubMed ID: 3416553
[TBL] [Abstract][Full Text] [Related]
11. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
13. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of aspirin on platelet aggregation in IDDM.
Mori TA; Vandongen R; Douglas AJ; McCulloch RK; Burke V
Diabetes; 1992 Mar; 41(3):261-6. PubMed ID: 1551486
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats.
Behrend EN; Grauer GF; Greco DS; Rose BJ; Thrall MA
J Am Anim Hosp Assoc; 1996; 32(1):11-8. PubMed ID: 8963730
[TBL] [Abstract][Full Text] [Related]
17. Why single daily dose of aspirin may not prevent platelet aggregation.
Altman R; Scazziota A; Funes JC
Thromb Res; 1988 Aug; 51(3):259-66. PubMed ID: 3140408
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
Lin CH; Kuo YH; Lin YL; Teng CM
J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
[TBL] [Abstract][Full Text] [Related]
19. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
Lauri D; Cerletti C; de Gaetano G
Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
[TBL] [Abstract][Full Text] [Related]
20. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]